Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use

The present invention relates to combinations comprising a positive allosteric modulator ("PAM") of metabotropic glutamatergic receptor subtype 2 ("mGluR2") or a pharmaceutically acceptable salt or a solvate thereof, or an orthosteric agonist of metabotropic glutamatergic 5 recep...

Full description

Saved in:
Bibliographic Details
Main Authors Cid-Nunez, Jose Maria, Klein, Brian D, Ceusters, Marc Andre, Bone, Roger Francis, Twyman, Roy E, White, H. Steven, Van Osselaer, Nancy Eulalie Sylvain, Trabanco-Suárez, Andrés Avelino, Lavreysen, Hilde, Pype, Stefan Maria Christiaan
Format Patent
LanguageEnglish
Published 19.01.2023
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention relates to combinations comprising a positive allosteric modulator ("PAM") of metabotropic glutamatergic receptor subtype 2 ("mGluR2") or a pharmaceutically acceptable salt or a solvate thereof, or an orthosteric agonist of metabotropic glutamatergic 5 receptor subtype 2 compound or a pharmaceutically acceptable salt or a solvate thereof, and a synaptic vesicle protein 2A ("SV2A") ligand.
Bibliography:Application Number: AU20210200512